1. A study published in mBio may help create a test to predict which hospital patients are at the highest risk of developing a C. diff infection and improve infection management. Read more.
2. An increase in C. diff infection incidence has been associated with poor outcomes among hospitalized children. A study in Infection Control & Hospital Epidemiology identified risk factors for all-cause in-hospital mortality among children with C. diff. Read more.
3. Disinfecting rooms with pulsed xenon ultraviolet light was linked to a reduction in intensive care unit-acquired C. diff infections, a study in the American Journal of Infection Control found. Read more.
4. Infants and young children who take acid-reducing medications are at a much higher risk of developing a C. diff infection, according to research published in Clinical Infectious Diseases. Read more.
5. Researchers conducted a study to determine the effect of transfers of patients between different hospitals on the rate of C. diff infections in a hospital. Read more.
6. Physicians and nurses don’t see eye to eye on which risk factors are considered most important when determining whether to test patients for C. diff, a study in the American Journal of Infection Control found. Read more.
7. Researchers from the University of Toronto determined the economic impact C. diff infections have on hospitals. Read more.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
